Racial Differences in Survival of Hepatocellular Carcinoma in the United States: A Population-Based Study Jessica A. Davila, Hashem B. El–Serag Clinical Gastroenterology and Hepatology Volume 4, Issue 1, Pages 104-110 (January 2006) DOI: 10.1016/S1542-3565(05)00745-7 Copyright © 2006 American Gastroenterological Association Terms and Conditions
Figure 1 The cumulative observed survival within the first 3 years after HCC diagnosis categorized by race/ethnicity. Data are shown for patients with complete follow-up information diagnosed in 9 SEER registries during 1987–2001 (n = 9735). Clinical Gastroenterology and Hepatology 2006 4, 104-110DOI: (10.1016/S1542-3565(05)00745-7) Copyright © 2006 American Gastroenterological Association Terms and Conditions
Figure 2 The 1- and 3-year relative survival in 5 race/ethnic groups during 1987–2001. Relative survival is calculated as the ratio of the observed survival to the expected survival for a group of people in a general population that is similar to that of the patient group with respect to race, sex, age, and calendar period of observation. Clinical Gastroenterology and Hepatology 2006 4, 104-110DOI: (10.1016/S1542-3565(05)00745-7) Copyright © 2006 American Gastroenterological Association Terms and Conditions
Figure 3 Changes in the proportion of patients with HCC who received any therapy (local or surgical) during 3 time periods (1987–1991, 1992–1996, 1997–2001) by race. Clinical Gastroenterology and Hepatology 2006 4, 104-110DOI: (10.1016/S1542-3565(05)00745-7) Copyright © 2006 American Gastroenterological Association Terms and Conditions